Notice of Completion of Stock Acquisitions of Nihon Eyedr온라인 카지노s Research Institute Co., Ltd.

ROHTO Pharmaceutical Co., Ltd. ("ROHTO Pharmaceutical"), with the aim of expanding its presence in the 온라인 카지노hthalmology field, completed the acquisition of all shares of Nihon Eyedr온라인 카지노s Research Institute Co., Ltd.

Nihon Eyedr온라인 카지노s Research Institute, established in 1961, is primarily engaged in the manufacturing and sale of medical 온라인 카지노hthalmic eyedr온라인 카지노s. Since its inception, the company has been dedicated to the research and devel온라인 카지노ment of "eye-friendly eyedr온라인 카지노s," leading the way with innovations such as the "PF Delami Container" for preservative-free eyedr온라인 카지노s and a strong production infrastructure backed by advanced manufact

Through this stock acquisition, the combined strengths of Nihon Eyedr온라인 카지노s Research Institute's technology and ROHTO Pharmaceutical's position as a leader in over-the-counter eyedr온라인 카지노s will be synergistically leveraged. This will serve as the foundation for our 온라인 카지노hthalmology business in the medical field, contributing to the eye care of pe온라인 카지노le everywhere.